Teva Announces Over-The-Counter Availability of Plan B One-Step® (levonorgestrel) tablet 1.5 mg for All Consumers
NORTH WALES, Pa.--(BUSINESS WIRE)--
Teva Womens Health, the U.S subsidiary of Teva Pharmaceuticals, today
announced that the emergency contraceptive Plan B One-Step(levonorgestrel)
tablet 1.5 mg is now widely available in the aisles of major retailers
nationwide with no age or point-of-sale restrictions. Plan B One-Step
is the first emergency contraceptive to be available for
over-the-counter sale to all consumers.
Since the U.S. Food and Drug Administration approved Plan B One-Step
with no age or point-of-sale restrictions on June 20, we have worked
tirelessly to bring the product to market for all consumers as soon as
possible, said Martin Berndt, Vice President & General Manager, U.S.
Brand Pharmaceuticals, Teva Womens Health, Inc. The availability of
Plan B One-Step in the aisles of retailers nationwide
ensures improved access to a product that has been clinically evaluated
and is a safe and effective back-up birth control method for women of
all reproductive ages.
Despite the many highly effective birth control options available, none
are 100 percent effective at preventing pregnancy and inconsistent or
incorrect use can more than double the failure rate of many birth
control options. In fact, one survey found almost one-half of the women
who used emergency contraception reported fear of birth control failure
as a reason for use. With Plan B One-Stepavailable
nationwide, women of all ages can be in control of their reproductive
health by taking an additional step to prevent an unintended pregnancy
after contraceptive failure or unprotected sex.
Emergency contraception gives women a last chance to prevent pregnancy
after birth control failure or unprotected sex, said Jill DeSimone,
Senior Vice President & General Manager, Teva Global Women's Health.
Women have faced challenges to obtaining emergency contraception for
far too long, and the availability of Plan B One-Step in the
aisle for all consumers is a historic step forward.
Teva is committed to ensuring Plan B One-Step is available
to all women who need it. As such, the price of Plan B One-Step
to wholesale and retail outlets will remain unchanged as it transitions
over-the-counter. In addition to now being available in aisle, Plan B
One-Step will also continue to be sold to hospitals and
health clinics at a subsidized price for women who may not otherwise be
able to afford it.
As a leader in womens health, Teva is committed to supporting and
empowering women by providing access to Plan B One-Step when
they need it, continued DeSimone. Teva remains committed to ongoing
consumer education on Plan B One-Step and will continue to
work closely on education initiatives in partnership with healthcare
Consumers can learn more about Plan B One-Step by visiting www.PlanBOneStep.com,
where they can get reliable information about what the product is and is
not, when it should be taken, as well as review answers to frequently
asked questions. Consumers can also speak live with a healthcare
professional by calling a toll-free hotline (1-800-330-1271).
Plan B One-Step is a progestin-only emergency contraceptive
that can help prevent pregnancy after birth control failure or
unprotected sex. When taken within 72 hours (three days) after birth
control failure or unprotected sex, Plan B One-Step can help
prevent a pregnancy from occurring in about seven of eight women who
would have become pregnant otherwise. Plan B One-Step is not
an abortifacient and will not harm an existing pregnancy. Plan B One-Step
is a back-up method of preventing pregnancy, but it isnt regular birth
control and should not be used that way, as it is not as effective as
regular birth control methods used correctly. For additional
information, visit www.PlanBOneStep.com.
Plan B One-Step (levonorgestrel) is intended to prevent
pregnancy after known or suspected birth control failure or unprotected
Teva Womens Health, Inc. is a U.S.-based subsidiary of Teva
Pharmaceutical Industries Ltd., headquartered in Israel. The company
produces a wide range of womens healthcare products including oral
contraceptives, intrauterine contraception and hormone therapy
treatments for menopause and perimenopause. Teva Womens Health, Inc.
maintains a strong commitment to enhancing womens lives by actively
pursuing new areas of research and providing distinct pharmaceutical
options that meet womens needs and fit their lifestyles. Through close
engagement with women and healthcare providers, the company maintains an
in-depth understanding of the important health matters that affect women.
Teva PharmaceuticalsDenise Bradley, email@example.com
Source: Teva Womens Health